Skip to Content

642 Results Found

  • Review
  • Open Access
19 Citations
5,683 Views
30 Pages

Triple-negative breast cancer (TNBC) is usually the most malignant and aggressive mammary epithelial tumor characterized by the lack of expression for estrogen receptors and progesterone receptors, and the absence of epidermal growth factor receptor...

(This article belongs to the Special Issue Advances in Breast Disease: From Screening to Diagnosis and Therapy)
  • Article
  • Open Access
16 Citations
4,045 Views
11 Pages

Amaryllidaceae-Type Alkaloids from Pancratium maritimum: Apoptosis-Inducing Effect and Cell Cycle Arrest on Triple-Negative Breast Cancer Cells

  • Shirley A. R. Sancha,
  • Adriana V. Gomes,
  • Joana B. Loureiro,
  • Lucília Saraiva and
  • Maria José U. Ferreira

6 September 2022

Aiming to find Amaryllidaceae alkaloids against breast cancer, including the highly aggressive triple-negative breast cancer, the phytochemical study of Pancratium maritimum was carried out. Several Amaryllidaceae-type alkaloids, bearing scaffolds of...

(This article belongs to the Special Issue Bioactive Natural Compounds: Isolation, Analysis and Evaluation)
  • Article
  • Open Access
41 Citations
6,272 Views
17 Pages

Therapeutic Potential of a Novel αvβ3 Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type

  • Billy Samuel Hill,
  • Annachiara Sarnella,
  • Domenica Capasso,
  • Daniela Comegna and ,
  • Annarita Del Gatto,
  • Matteo Gramanzini,
  • Sandra Albanese,
  • Michele Saviano,
  • Laura Zaccaro and
  • Antonella Zannetti
  • + 5 authors+ 0 author

24 January 2019

The mesenchymal sub-type of triple negative breast cancer (MES-TNBC) has a highly aggressive behavior and worse prognosis, due to its invasive and stem-like features, that correlate with metastatic dissemination and resistance to therapies. Furthermo...

(This article belongs to the Special Issue Breast Cancer Stem Cells: Therapy Resistance and Novel Therapeutic Targets)
  • Article
  • Open Access
14 Citations
3,899 Views
11 Pages

Nuclear Expression of p-STAT3 Is Associated with Poor Prognosis in ER(−) Breast Cancer

  • Tsuyoshi Nakagawa,
  • Goshi Oda,
  • Hiroshi Kawachi,
  • Toshiaki Ishikawa and ,
  • Kentaro Okamoto and
  • Hiroyuki Uetake
  • + 1 author+ 0 author

25 February 2022

The activation of signal transducer and activator of transcription 3 (STAT3) has been reported in several types of cancer, where it acts as an oncogene. However, in breast cancer, the clinical role of STAT3 remains unclear. In the present study, the...

  • Article
  • Open Access
5 Citations
1,516 Views
20 Pages

31 October 2025

To date, breast cancer remains one of the leading causes of death among women worldwide. Although various treatments are used in clinical settings, the efficacy and safety of such treatments are limited by tumor biology factors and patient preference...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
18 Citations
5,863 Views
15 Pages

Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential

  • Charles S. Fermaintt,
  • Thilini Peramuna,
  • Shengxin Cai,
  • Leila Takahashi-Ruiz and ,
  • Jacob Nathaniel Essif,
  • Corena V. Grant,
  • Barry R. O’Keefe,
  • Susan L. Mooberry,
  • Robert H. Cichewicz and
  • April L. Risinger
  • + 5 authors+ 0 author

7 June 2021

The heterogeneity of triple negative breast cancer (TNBC) has led to efforts to further subtype this disease with the hope of identifying new molecular liabilities and drug targets. Furthermore, the finding that TNBC is the most inherently immunogeni...

(This article belongs to the Special Issue Medicinal Plants and Their Active Ingredients in Cancer)
  • Article
  • Open Access
9 Citations
3,457 Views
16 Pages

Cytotoxic Compounds from Belamcanda chinensis (L.) DC Induced Apoptosis in Triple-Negative Breast Cancer Cells

  • Ya-Ping Guo,
  • Peng Yi,
  • Qi-Qi Shi,
  • Rui-Rui Yu and ,
  • Jin-Hui Wang,
  • Chen-Yang Li and
  • Hai-Qiang Wu
  • + 2 authors+ 0 author

12 June 2023

Four compounds (1, 5, 7, and 8) were first isolated from the genus Belamcanda Adans. nom. conserv., and six known compounds (2–4, 6, 9, and 10) were isolated from the rhizome of Belamcanda chinensis (L.) DC. Their structures were confirmed by s...

  • Article
  • Open Access
820 Views
12 Pages

A Boronic Acid-Based Glutamine Analog Forms a Covalent Adduct with Kidney-Type Glutaminase and Suppresses Triple-Negative Breast Cancer Cell Proliferation

  • Thiruselvam Viswanathan,
  • Dinesh Devadoss,
  • Achyuta Nagaraj,
  • Barry P. Rosen and ,
  • Hitendra S. Chand and
  • Venkadesh Sarkarai Nadar
  • + 1 author+ 0 author

Background: Cancer cells exhibit metabolic reprogramming characterized by increased dependence on glutamine to sustain rapid proliferation and biosynthetic demands. Kidney-type glutaminase (KGA), which catalyzes the first and rate-limiting step of gl...

(This article belongs to the Special Issue Anti-Cancer Agents: Synthesis and Evaluation of Pharmacological Activity)
  • Article
  • Open Access
236 Views
19 Pages

Matrix-Associated Gene Expression and Annotated Tumor–Stroma Composition of Transcriptomically Defined Cold Regions in Triple-Negative Breast Cancer

  • William D. Lituma-Gonzalez,
  • Amogh V. Arunprasad,
  • Hugo Chancay,
  • Varshithaa Jayavelan and ,
  • Meenakshi Chakravadhanula,
  • Santiago Ballaz and
  • Shanmugamurthy Lakshmanan
  • + 2 authors+ 0 author

28 October 2026

Background/Objectives: Regional transcriptomic labels can reflect cell mixtures and expression states. We examined how transcriptomically defined cold regions in triple-negative breast cancer relate to matrix-associated expression, annotated composit...

(This article belongs to the Section Tumor Microenvironment)
  • Article
  • Open Access
11 Citations
2,947 Views
24 Pages

Mixed-Valence Pentadecavanadate with Ca2+-ATPase Inhibition Potential and Anti-Breast Cancer Activity

  • Bianca R. Brito,
  • Heloísa de S. Camilo,
  • Anderson F. da Cruz,
  • Ronny R. Ribeiro and ,
  • Eduardo L. de Sá,
  • Carolina Camargo de Oliveira,
  • Gil Fraqueza,
  • Giseli Klassen,
  • Manuel Aureliano and
  • Giovana G. Nunes
  • + 5 authors+ 0 author

12 September 2025

Polyoxovanadates are a subclass of polyoxometalates (POMs) known to interact with proteins and to present anticancer, antimicrobial, and antiviral activities. Herein, we aimed to pursue the study of the breast anticancer activity of a mixed-valence p...

(This article belongs to the Section Bioinorganic Chemistry)
  • Article
  • Open Access
2,947 Views
21 Pages

A Novel Cytotoxic Mechanism for Triple-Negative Breast Cancer Cells Induced by the Type II Heat-Labile Enterotoxin LT-IIc through Ganglioside Ligation

  • Natalie D. King-Lyons,
  • Aryana S. Bhati,
  • John C. Hu,
  • Lorrie M. Mandell and ,
  • Gautam N. Shenoy,
  • Hugh J. Willison and
  • Terry D. Connell
  • + 2 authors+ 0 author

11 July 2024

Triple-negative breast cancer (TNBC), which constitutes 10–20 percent of all breast cancers, is aggressive, has high metastatic potential, and carries a poor prognosis due to limited treatment options. LT-IIc, a member of the type II subfamily...

(This article belongs to the Section Bacterial Toxins)
  • Article
  • Open Access
22 Citations
6,043 Views
20 Pages

LT-IIc, A Bacterial Type II Heat-Labile Enterotoxin, Induces Specific Lethality in Triple Negative Breast Cancer Cells by Modulation of Autophagy and Induction of Apoptosis and Necroptosis

  • Patricia Masso-Welch,
  • Sofia Girald Berlingeri,
  • Natalie D. King-Lyons,
  • Lorrie Mandell and ,
  • John Hu,
  • Christopher J. Greene,
  • Matthew Federowicz,
  • Peter Cao,
  • Terry D. Connell and
  • Yasser Heakal
  • + 5 authors+ 0 author

Triple negative breast cancer (TNBC) remains a serious health problem with poor prognosis and limited therapeutic options. To discover novel approaches to treat TNBC, we screened cholera toxin (CT) and the members of the bacterial type II heat-labile...

(This article belongs to the Section Molecular Oncology)
  • Review
  • Open Access
92 Citations
11,742 Views
30 Pages

Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type

  • Md Abdus Subhan,
  • Farzana Parveen,
  • Hassan Shah,
  • Satya Siva Kishan Yalamarty and ,
  • Janaína Artem Ataide and
  • Valdimir P. Torchilin
  • + 1 author+ 0 author

8 April 2023

Breast cancer is a heterogeneous disease with different molecular subtypes. Breast cancer is the second leading cause of mortality in woman due to rapid metastasis and disease recurrence. Precision medicine remains an essential source to lower the of...

(This article belongs to the Special Issue Precision Medicine in Breast Cancer Treatment)
  • Article
  • Open Access
30 Citations
5,174 Views
22 Pages

The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models

  • Leila Takahashi-Ruiz,
  • Charles S. Fermaintt,
  • Nancy J. Wilkinson,
  • Peter Y. W. Chan and ,
  • Susan L. Mooberry and
  • April L. Risinger
  • + 1 author+ 0 author

2 December 2022

Eribulin is a microtubule destabilizer used in the treatment of triple-negative breast cancer (TNBC). Eribulin and other microtubule targeted drugs, such as the taxanes, have shared antimitotic effects, but differ in their mechanism of microtubule di...

(This article belongs to the Special Issue Immunotherapy of Triple-Negative Breast Cancer)
  • Article
  • Open Access
5 Citations
2,328 Views
22 Pages

Reduced Taurine Synthesis Underlies Morphine-Promoted Lung Metastasis of Triple-Negative Breast Cancer

  • Shih-Hong Chen,
  • Ting-Ling Ke,
  • Chien-Hung Shih,
  • Chia-Ni Hsiung and ,
  • Kuo-Chin Chen,
  • Zi-Xuan Huang,
  • Tsung-Hsien Chuang,
  • Li-Kuei Chen and
  • Linyi Chen
  • + 4 authors+ 0 author

24 March 2025

Background: The mechanisms underlying the progression and metastasis of triple-negative breast cancer (TNBC) in the context of extended morphine exposure remain poorly understood. Morphine consumption has been a pressing issue in many countries. Whil...

(This article belongs to the Section Cancer Metastasis)
  • Article
  • Open Access
4 Citations
2,954 Views
17 Pages

Targeting p70S6K1 Inhibits Glycated Albumin-Induced Triple-Negative Breast Cancer Cell Invasion and Overexpression of Galectin-3, a Potential Prognostic Marker in Diabetic Patients with Invasive Breast Cancer

  • Fatimah Alanazi,
  • Abdulmonem A. Alsaleh,
  • Mariam K. Alamoudi,
  • Abdulrahman Alasiri and ,
  • Amanda Haymond and
  • Sabine Matou-Nasri
  • + 1 author+ 0 author

Background: There is an urgent need to identify new biomarkers for early diagnosis and development of therapeutic strategies for diabetes mellitus (DM) patients who have invasive breast cancer (BC). We previously reported the increased activated form...

(This article belongs to the Section Cell Biology and Pathology)
  • Article
  • Open Access
289 Views
28 Pages

Defined Extracellular Matrix Contexts Rewire 3D Breast Cancer Cell Models: Effects of Sulfated Hyaluronan in the Expression of Matrix Effector and Matrix-Based Cell Functional Properties

  • Marios Vetoulas,
  • Maria Drosinou,
  • Nikoleta Alexiou,
  • Angeliki Farmaki and ,
  • Zoi Piperigkou and
  • Nikos K. Karamanos
  • + 1 author+ 0 author

12 October 2026

Background: Breast cancer progression is strongly influenced by tumor cell interactions with the extracellular matrix (ECM). Three-dimensional (3D) cell culture models provide more relevant systems for studying aspects of the tumor microenvironment (...

(This article belongs to the Special Issue Decoding the Dynamic Matrix Complexity in Cancer)
  • Article
  • Open Access
14 Citations
2,733 Views
11 Pages

26 November 2023

Background: The National Comprehensive Cancer Network guidelines were designed to improve patient outcomes. Here, we examine factors that may contribute to outcomes and guideline adherence in patients with triple-negative breast cancer. Methods: This...

(This article belongs to the Special Issue Advances in Invasive Breast Cancer: Treatment and Prognosis)
  • Article
  • Open Access
252 Citations
21,310 Views
12 Pages

20 January 2021

Background: Breast cancer is a heterogeneous disease defined by molecular types and subtypes. Advances in genomic research have enabled use of precision medicine in clinical management of breast cancer. A critical unmet medical need is distinguishing...

(This article belongs to the Special Issue Use of Clinical Decision Support Software within Health Care Systems)
  • Article
  • Open Access
10 Citations
5,119 Views
11 Pages

7 June 2020

Translation-based knowledge graph embeddings learn vector representations of entities and relations by treating relations as translation operators over the entities in an embedding space. Since the translation is represented through a score function,...

(This article belongs to the Special Issue Knowledge Retrieval and Reuse)
  • Article
  • Open Access
18 Citations
8,263 Views
13 Pages

Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy

  • Taobo Hu,
  • Yiqiang Liu,
  • Jinbo Wu,
  • Xuejiao Lina Hu and ,
  • Guiyang Zhao,
  • Baosheng Liang,
  • Shu Wang and
  • Mengping Long
  • + 3 authors+ 0 author

14 March 2022

Apocrine carcinoma is a rare subtype of invasive ductal breast cancer that shows apocrine differentiation and largely triple-negative immunohistology. Triple-negative breast cancers are known to have more aggressive clinical courses. However, unlike...

(This article belongs to the Special Issue Current Updates and Advances in Breast Cancer)
  • Article
  • Open Access
6 Citations
4,667 Views
22 Pages

27 April 2020

Triple negative breast cancer is a collection of heterogeneous breast cancers that are immunohistochemically negative for estrogen receptor, progesterone receptor, and ErbB2 (due to deletion or lack of amplification). No dominant proliferative driver...

  • Review
  • Open Access
28 Citations
6,135 Views
20 Pages

14 February 2023

Triple-negative breast cancer is the most potent metastatic type of breast cancer that can spread to other body parts. Chemotherapy and surgical intervention are the sole treatments for TNBC, owing to the scarcity of therapeutic targets. Manipulation...

(This article belongs to the Special Issue Natural Products in Anticancer Activity)
  • Article
  • Open Access
13 Citations
4,811 Views
24 Pages

6 February 2021

The aryl hydrocarbon receptor (AHR) is a ligand-activated signaling molecule expressed in many cell types, including triple-negative and non-triple-negative breast cancer cells. It affects breast cancer growth and crosstalk with estrogen receptor sig...

(This article belongs to the Section Molecular Pharmacology)
  • Article
  • Open Access
44 Citations
10,219 Views
16 Pages

8 October 2019

In our previous study, Deferoxamine (DFO) increased the iron concentration by upregulating the expression levels of TfR1 and DMT1 and exacerbated the migration of triple-negative breast cancer cells. However, the mechanisms of iron distribution and u...

(This article belongs to the Special Issue Advances on Chelation in Medicine)
  • Article
  • Open Access
2 Citations
4,285 Views
13 Pages

Is It Possible to Predict Clonal Thrombocytosis in Triple-Negative Patients with Isolated Thrombocytosis Based Only on Clinical or Blood Findings?

  • Tanja Belčič Mikič,
  • Bor Vratanar,
  • Tadej Pajič,
  • Saša Anžej Doma and ,
  • Nataša Debeljak,
  • Irena Preložnik Zupan,
  • Matjaž Sever and
  • Samo Zver
  • + 3 authors+ 0 author

11 December 2021

JAK2, MPL, and CALR mutations define clonal thrombocytosis in about 90% of patients with sustained isolated thrombocytosis. In the remainder of patients (triple-negative patients) diagnosing clonal thrombocytosis is especially difficult due to the di...

(This article belongs to the Special Issue Diagnosis and Management of Blood Diseases)
  • Article
  • Open Access
3 Citations
3,511 Views
18 Pages

The Cytoplasmic Region of SARAF Reduces Triple-Negative Breast Cancer Metastasis through the Regulation of Store-Operated Calcium Entry

  • María Paz Saldías,
  • Pablo Cruz,
  • Ian Silva,
  • Octavio Orellana-Serradell and ,
  • Boris Lavanderos,
  • Diego Maureira,
  • Raquel Pinto and
  • Oscar Cerda
  • + 3 authors+ 0 author

Triple-negative breast cancer has a poor prognosis and is non-responsive to first-line therapies; hence, new therapeutic strategies are needed. Enhanced store-operated Ca2+ entry (SOCE) has been widely described as a contributing factor to tumorigeni...

(This article belongs to the Special Issue TRP Channels in Cancer: New Avenues for Diagnosis, Prognostication, and Therapy)
  • Article
  • Open Access
51 Citations
8,133 Views
17 Pages

Anticancer Effect of Citrus hystrix DC. Leaf Extract and Its Bioactive Constituents Citronellol and, Citronellal on the Triple Negative Breast Cancer MDA-MB-231 Cell Line

  • Yathsoeung Ho,
  • Nungruthai Suphrom,
  • Krai Daowtak,
  • Pachuen Potup and ,
  • Yordhathai Thongsri and
  • Kanchana Usuwanthim
  • + 1 author+ 0 author

18 December 2020

Triple negative breast cancer is one of the most aggressive breast cancer type with abilities of early metastasis and chemoresistance. The tropical plant Citrus hystrix DC. has been reported to promote many biological activities including anticancer....

(This article belongs to the Special Issue Anticancer Compounds in Medicinal Plants)
  • Review
  • Open Access
92 Citations
12,534 Views
23 Pages

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis

  • Gábor Cserni,
  • Cecily M. Quinn,
  • Maria Pia Foschini,
  • Simonetta Bianchi and ,
  • Grace Callagy,
  • Ewa Chmielik,
  • Thomas Decker,
  • Falko Fend,
  • Anikó Kovács and
  • European Working Group for Breast Screening Pathology
  • + 9 authors+ 4 authors

14 November 2021

Triple-negative breast cancers (TNBC), as a group of tumours, have a worse prognosis than stage-matched non-TNBC and lack the benefits of routinely available targeted therapy. However, TNBC is a heterogeneous group of neoplasms, which includes some s...

(This article belongs to the Special Issue Novel Biomarkers: Validity, Evaluation and Biological Roles for Breast Cancer)
  • Review
  • Open Access
4 Citations
2,214 Views
25 Pages

Guardians in the Gut: Mechanistic Insights into a Hidden Ally Against Triple-Negative Breast Cancer

  • Kayla Jaye,
  • Muhammad A. Alsherbiny,
  • Dennis Chang,
  • Chun-Guang Li and
  • Deep Jyoti Bhuyan

7 October 2025

The gut microbiome possesses a diverse range of biological properties that play a role in maintaining host health and preventing disease. Gut microbial metabolites, including short-chain fatty acids, natural purine nucleosides, ellagic acid derivativ...

(This article belongs to the Special Issue Gut Microbiome, Diet and Cancer Risk)
  • Article
  • Open Access

18 November 2026

Background and Objectives: Adenoid cystic carcinoma of the breast is a rare special-type tumor that is characteristically triple-negative yet behaves indolently, unlike conventional triple-negative disease. How its mortality is divided between the ca...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
10 Citations
4,086 Views
15 Pages

PKR-Mediated Phosphorylation of eIF2a and CHK1 Is Associated with Doxorubicin-Mediated Apoptosis in HCC1143 Triple-Negative Breast Cancer Cells

  • Sol Lee,
  • Ha-Yeon Jee,
  • Yoon-Gyeong Lee,
  • Jong-Il Shin and ,
  • Yong-Joon Jeon,
  • Ji-Beom Kim,
  • Hye-eun Seo,
  • Ji-Yeon Lee and
  • Kyungho Lee
  • + 4 authors+ 0 author

14 December 2022

Triple-negative breast cancer is more aggressive than other types of breast cancer. Protein kinase R (PKR), which is activated by dsRNA, is known to play a role in doxorubicin-mediated apoptosis; however, its role in DNA damage-mediated apoptosis is...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
1 Citations
3,909 Views
22 Pages

Universal Knowledge Graph Embedding Framework Based on High-Quality Negative Sampling and Weighting

  • Pengfei Zhang,
  • Huang Peng,
  • Yang Fang,
  • Zongqiang Yang and ,
  • Yanli Hu,
  • Zhen Tan and
  • Weidong Xiao
  • + 2 authors+ 0 author

8 November 2024

The traditional model training approach based on negative sampling randomly samples a portion of negative samples for training, which can easily overlook important negative samples and adversely affect the training of knowledge graph embedding models...

  • Review
  • Open Access
30 Citations
5,712 Views
17 Pages

Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma

  • Silvia González-Martínez,
  • Belén Pérez-Mies,
  • David Pizarro,
  • Tamara Caniego-Casas and ,
  • Javier Cortés and
  • José Palacios
  • + 1 author+ 0 author

Metaplastic breast carcinoma (MBC) is a heterogeneous group of infrequent triple negative (TN) invasive carcinomas with poor prognosis. MBCs have a different clinical behavior from other types of triple negative breast cancer (TNBC), being more resis...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
27 Citations
4,856 Views
15 Pages

Combination of OX40 Co-Stimulation, Radiotherapy, and PD-1 Inhibition in a Syngeneic Murine Triple-Negative Breast Cancer Model

  • Min Guk Han,
  • Chan Woo Wee,
  • Mi Hyun Kang,
  • Min Ji Kim and ,
  • Seung Hyuck Jeon and
  • In Ah Kim
  • + 1 author+ 0 author

29 May 2022

Immune checkpoint inhibitors have been successful in a wide range of tumor types but still have limited efficacy in immunologically cold tumors, such as breast cancers. We hypothesized that the combination of agonistic anti-OX40 (α-OX40) co-sti...

(This article belongs to the Topic Anti-Tumor Immune Responses)
  • Article
  • Open Access
9 Citations
4,103 Views
13 Pages

Breast Tumour Kinase (Brk/PTK6) Contributes to Breast Tumour Xenograft Growth and Modulates Chemotherapeutic Responses In Vitro

  • Rajpal S. Burmi,
  • Gary M. Box,
  • Umar Wazir,
  • Haroon A. Hussain and ,
  • Julie A. Davies,
  • William J. Court,
  • Suzanne A. Eccles,
  • Wen G. Jiang,
  • Kefah Mokbel and
  • Amanda J. Harvey
  • + 5 authors+ 0 author

24 February 2022

Breast tumour kinase (Brk/PTK6) is overexpressed in up to 86% of breast cancers and is associated with poorer patient outcomes. It is considered a potential therapeutic target in breast cancer, even though the full spectrum of its kinase activity is...

(This article belongs to the Special Issue Signaling Pathway of Cancer)
  • Article
  • Open Access
1 Citations
5,520 Views
9 Pages

Background and Objectives: Philadelphia (Ph)-negative myeloproliferative neoplasms can exhibit defects in Janus kinase 2 (JAK2), Calreticulin (CalR), and MPL genes. It is possible that the presence of other driver mutations may influence diagnosis an...

(This article belongs to the Topic Cancer Biology and Radiation Therapy: 2nd Edition)
  • Systematic Review
  • Open Access
11 Citations
7,566 Views
29 Pages

Sacituzumab Govitecan in Triple Negative Breast Cancer: A Systematic Review of Clinical Trials

  • Marcelino Pérez-Bermejo,
  • Mónica Caballero-Pascual,
  • María Ester Legidos-García,
  • Miriam Martínez-Peris and ,
  • Jorge Casaña-Mohedo,
  • Francisco Llorca-Colomer,
  • Ignacio Ventura,
  • Francisco Tomás-Aguirre,
  • Adalberto Asins-Cubells and
  • María Teresa Murillo-Llorente
  • + 5 authors+ 0 author

27 October 2024

Background/Objectives: Triple-negative breast cancer is difficult to treat due to the absence of hormone receptors and Her2neu. Sacituzumab govitecan is a new therapeutic approach that uses an antibody directed against the Trop-2 antigen present in s...

(This article belongs to the Section Systematic Review or Meta-Analysis in Cancer Research)
  • Article
  • Open Access
16 Citations
4,798 Views
13 Pages

Spatial Profile of Tumor Microenvironment in PD-L1-Negative and PD-L1-Positive Triple-Negative Breast Cancer

  • Liubov A. Tashireva,
  • Anna Yu. Kalinchuk,
  • Tatiana S. Gerashchenko,
  • Maksim Menyailo and ,
  • Anna Khozyainova,
  • Evgeniy V. Denisov and
  • Vladimir M. Perelmuter
  • + 2 authors+ 0 author

11 January 2023

The problem of finding more precise stratification criteria for identifying the cohort of patients who would obtain the maximum benefit from immunotherapy is acute in modern times. In our study were enrolled 18 triple-negative breast cancer patients....

(This article belongs to the Special Issue Molecular Biomarkers in Cancer and Chronic Inflammation: New Therapeutic Approaches)
  • Article
  • Open Access
359 Views
24 Pages

The Impact of the Antidiabetic Agent Sitagliptin on the Radiation Response of Breast Carcinoma Cells with Different Metastatic Capacities

  • Marie Theres Eling,
  • Anouk Bottema,
  • Dragana Savic,
  • Sergej Skvortsov and ,
  • Ute Ganswindt,
  • Petra Obexer and
  • Ira Ida Skvortsova
  • + 2 authors+ 0 author

15 October 2026

Breast cancer (BC) and type 2 diabetes mellitus (T2DM) often co-occur and can contribute to poorer clinical outcomes after therapy compared to non-diabetic cases. It is assumed that glucose-lowering drugs like DPP4 inhibitors (DPP4-Is), e.g., sitagli...

(This article belongs to the Special Issue Cellular and Molecular Mechanisms of Breast Cancer)
  • Case Report
  • Open Access
15 Citations
3,794 Views
10 Pages

Tall Cell Carcinoma with Reversed Polarity: Case Report of a Rare Special Type of Breast Cancer and Review of the Literature

  • Maiar Elghobashy,
  • Stephanie Jenkins,
  • Zachary Shulman,
  • Anne O’Neil and ,
  • Sofia Kouneli and
  • Abeer M. Shaaban
  • + 1 author+ 0 author

Background: Tall cell carcinoma of the breast with reversed polarity (TCCRP) is a rare type of invasive breast cancer with overlapping features with papillary thyroid carcinoma and a characteristic molecular profile. Few cases have been reported in t...

(This article belongs to the Special Issue Molecular Research of Triple-Negative Breast Cancer)
  • Review
  • Open Access
6 Citations
3,067 Views
15 Pages

Predictive Factors of Response to Neoadjuvant Chemotherapy (NACT) and Immune Checkpoint Inhibitors in Early-Stage Triple-Negative Breast Cancer Patients (TNBC)

  • Khashayar Yazdanpanah Ardakani,
  • Francesca Fulvia Pepe,
  • Serena Capici,
  • Thoma Dario Clementi and
  • Marina Elena Cazzaniga

Triple-negative breast cancer (TNBC) is a heterogenous group of breast tumors. This type of breast tumor is relatively difficult to manage, due to the lack of expression of Hormone Receptors (HR) and human epidermal growth factor receptor (HER2). Eff...

(This article belongs to the Section Breast Cancer)
  • Article
  • Open Access
11 Citations
3,451 Views
21 Pages

Combination of Immune-Related Network and Molecular Typing Analysis Defines a Three-Gene Signature for Predicting Prognosis of Triple-Negative Breast Cancer

  • Jinguo Zhang,
  • Shuaikang Pan,
  • Chaoqiang Han,
  • Hongwei Jin and ,
  • Qingqing Sun,
  • Jun Du and
  • Xinghua Han
  • + 2 authors+ 0 author

25 October 2022

Recent breakthroughs in immune checkpoint inhibitors (ICIs) have shown promise in triple-negative breast cancer (TNBC). Due to the intrinsic heterogeneity among TNBC, clinical response to ICIs varies greatly among individuals. Thus, discovering ratio...

(This article belongs to the Topic Adaptation Mechanisms in Therapy-Resistant Breast Cancer)
  • Feature Paper
  • Article
  • Open Access
24 Citations
5,948 Views
16 Pages

A Novel Polyhalogenated Monoterpene Induces Cell Cycle Arrest and Apoptosis in Breast Cancer Cells

  • Menna El Gaafary,
  • Susanne Hafner,
  • Sophia J. Lang,
  • Lu Jin and ,
  • Omar M. Sabry,
  • Carl V. Vogel,
  • Christopher D. Vanderwal,
  • Tatiana Syrovets and
  • Thomas Simmet
  • + 4 authors+ 0 author

25 July 2019

Breast cancer is the most common cancer type and a primary cause of cancer mortality among females worldwide. Here, we analyzed the anticancer efficacy of a novel bromochlorinated monoterpene, PPM1, a synthetic analogue of polyhalogenated monoterpene...

  • Article
  • Open Access
1 Citations
5,045 Views
12 Pages

Efficacy and Safety of Dose-Dense Chemotherapy in Breast Cancer: Real Clinical Data and Literature Review

  • Keiko Yanagihara,
  • Masato Yoshida,
  • Tamami Yamakawa,
  • Sena Kato and ,
  • Miki Tamura and
  • Koji Nagata
  • + 1 author+ 0 author

Dose-dense chemotherapy shortens the interval between chemotherapy cycles and has shown improved outcomes in high-risk breast cancer patients. We retrospectively evaluated the efficacy and safety of dose-dense chemotherapy in 80 breast cancer patient...

(This article belongs to the Special Issue From Screening to Treatment: Technology’s Impact on Breast Cancer Care)
  • Case Report
  • Open Access
2,231 Views
8 Pages

An Unusual Presentation of Synchronous Breast Cancer and Skin Malignancy in a Patient with Lynch Syndrome: A Case Report and Review of the Literature

  • Maiar Elghobashy,
  • Michael Siafakas,
  • Mona Elshafie,
  • Rahul Hejmadi and ,
  • Naren N. Basu and
  • Abeer M. Shaaban
  • + 1 author+ 0 author

Background: Lynch syndrome is an autosomal dominant condition that leads to an increased risk of many neoplasms. In the United Kingdom, NICE recommends that patients with colorectal and endometrial cancer should be tested for Lynch syndrome. There is...

(This article belongs to the Section Cancer Biology and Oncology)
  • Article
  • Open Access
20 Citations
5,778 Views
17 Pages

Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis

  • Anna Wawruszak,
  • Jarogniew J. Luszczki,
  • Joanna Kalafut,
  • Karolina Okla and ,
  • Marta Halasa,
  • Adolfo Rivero-Muller and
  • Andrzej Stepulak
  • + 2 authors+ 0 author

The aim of this study was to investigate the influence of the Notch1 activity level on the pharmacological interaction between cisplatin (CDDP) and two histone deacetylase inhibitors (HDIs)—valproic acid (VPA) and vorinostat (SAHA) in the tripl...

(This article belongs to the Special Issue Cisplatin in Cancer Therapy: Molecular Mechanisms of Action)
  • Review
  • Open Access
14 Citations
6,237 Views
12 Pages

The Role of Patient-Derived Organoids in Triple-Negative Breast Cancer Drug Screening

  • Iason Psilopatis,
  • Amalia Mantzari,
  • Kleio Vrettou and
  • Stamatios Theocharis

Triple-negative breast cancer (TNBC) is one of the most aggressive breast cancer subtypes, with a grave prognosis and few effective treatment options. Organoids represent revolutionary three-dimensional cell culture models, derived from stem or diffe...

(This article belongs to the Section Biomedical Engineering and Materials)
  • Article
  • Open Access
29 Citations
8,610 Views
19 Pages

Inorganic Phosphate Prevents Erk1/2 and Stat3 Activation and Improves Sensitivity to Doxorubicin of MDA-MB-231 Breast Cancer Cells

  • Luigi Sapio,
  • Luca Sorvillo,
  • Michela Illiano,
  • Emilio Chiosi and ,
  • Annamaria Spina and
  • Silvio Naviglio
  • + 1 author+ 0 author

1 September 2015

Due to its expression profile, triple-negative breast cancer (TNBC) is refractory to the most effective targeted therapies available for breast cancer treatment. Thus, cytotoxic chemotherapy represents the mainstay of treatment for early and metastat...

(This article belongs to the Collection Nanomedicine)
  • Article
  • Open Access
28 Citations
3,746 Views
19 Pages

7 December 2022

Breast cancer accounts for almost one quarter of all female cancers worldwide, and more than 90% of those who are diagnosed with breast cancer undergo mastectomy or breast conservation surgery. Local anesthetics effectively inhibit the invasion of ca...

(This article belongs to the Special Issue Autophagy in Health, Aging and Disease 3.0)

of 13